TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

NewsGuard 100/100 Score

TechniScan, Inc., (OTC Bulletin Board: TSNI) the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

The patent titled "Apparatus and Method for Imaging Objects with Wave Fields" outlines how the company's groundbreaking algorithms are translated into a high resolution, 3-D ultrasound image of the human breast. The patent also includes recursive methods for increasing the speed that the images are processed, which may deliver faster clinical outcomes for women awaiting breast-imaging results.

"This patent is another example of the deep portfolio of unique IP (intellectual property) that has resulted from our 20 years of research in the fields of mathematics and physics. The patent is a result of extensive work by our entire team to extract the benefits of complex transmission wave field imaging methods," said Dave Robinson, chief executive officer at TechniScan.

The science developed at TechniScan, Inc. has led to new ways of utilizing whole breast ultrasound technology that may more accurately distinguish pathological from normal breast tissue. The images are captured using a comfortable, radiation-free method as a woman lies prone on an examination table and ultrasound is directed, using warm water as a coupling medium, through her breast tissue.

SOURCE TechniScan, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Survey unveils India's rising tide of metabolic diseases